153 related articles for article (PubMed ID: 11548844)
1. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
Comoli P; Locatelli F; Moretta A; Montagna D; Calcaterra V; Cometa A; Basso S; Zecca M; Maccario R
Bone Marrow Transplant; 2001 Jun; 27(12):1263-73. PubMed ID: 11548844
[TBL] [Abstract][Full Text] [Related]
2. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
3. Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.
Taub DD; Murphy WJ; Asai O; Fenton RG; Peltz G; Key ML; Turcovski-Corrales S; Longo DL
J Immunol; 1997 Mar; 158(6):2745-55. PubMed ID: 9058809
[TBL] [Abstract][Full Text] [Related]
4. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
5. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation.
Van Gool SW; Ceuppens JL; Walter H; de Boer M
Blood; 1994 Jan; 83(1):176-83. PubMed ID: 7506079
[TBL] [Abstract][Full Text] [Related]
6. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
7. Effects of B7-blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura.
Peng J; Liu C; Liu D; Ren C; Li W; Wang Z; Xing N; Xu C; Chen X; Ji C; Zhang M; Hou M
Blood; 2003 Apr; 101(7):2721-6. PubMed ID: 12446456
[TBL] [Abstract][Full Text] [Related]
8. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool.
Gribben JG; Guinan EC; Boussiotis VA; Ke XY; Linsley L; Sieff C; Gray GS; Freeman GJ; Nadler LM
Blood; 1996 Jun; 87(11):4887-93. PubMed ID: 8639863
[TBL] [Abstract][Full Text] [Related]
9. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
11. CTLA4-Ig: a novel immunosuppressive agent.
Najafian N; Sayegh MH
Expert Opin Investig Drugs; 2000 Sep; 9(9):2147-57. PubMed ID: 11060799
[TBL] [Abstract][Full Text] [Related]
12. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of anergic histoincompatible bone marrow allografts.
Guinan EC; Boussiotis VA; Neuberg D; Brennan LL; Hirano N; Nadler LM; Gribben JG
N Engl J Med; 1999 Jun; 340(22):1704-14. PubMed ID: 10352162
[TBL] [Abstract][Full Text] [Related]
14. B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Bai XF; Liu J; May KF; Guo Y; Zheng P; Liu Y
Blood; 2002 Apr; 99(8):2880-9. PubMed ID: 11929778
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
[TBL] [Abstract][Full Text] [Related]
16. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
Lin H; Rathmell JC; Gray GS; Thompson CB; Leiden JM; Alegre ML
J Exp Med; 1998 Jul; 188(1):199-204. PubMed ID: 9653096
[TBL] [Abstract][Full Text] [Related]
18. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis.
Israël-Assayag E; Fournier M; Cormier Y
J Immunol; 1999 Dec; 163(12):6794-9. PubMed ID: 10586079
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro.
Koenen HJ; Fasse E; Joosten I
Transplantation; 2005 Aug; 80(4):522-9. PubMed ID: 16123728
[TBL] [Abstract][Full Text] [Related]
20. Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.
Blazevic V; Pinto LA; Trubey CM; Shearer GM
J Leukoc Biol; 2000 Jun; 67(6):817-24. PubMed ID: 10857854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
